Kramer was the CEO of Emergent BioSolutions, a government contractor hired to mass produce coronavirus vaccine doses, 400 ...

Hair loss–focused Veradermics and cancer biotech Eikon follow the lead of Aktis Oncology, which last week announced a $318 ...

On the last trading day of 2025, Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several portfolio moves across ...

Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak. That patience is finally paying ...

Moderna shares surge 30% in 2026 on raised revenue forecast and cost cuts. Technical breakout suggests continued momentum ...

Zhengye receives a Nasdaq notice for failing to file its 2024 annual report on time. The company has 60 days to submit a compliance plan to avoid potential delisting. Get special access to three ...

I favor biotech stocks trading below cash value after setbacks; Arvinas (ARVN) fits this description, dropping 25% on Thursday after ending two Phase 3 trials. ARVN's net cash per share is over $12, ...

IO Biotech, Inc. (NASDAQ:IOBT – Get Free Report)’s share price rose 1.4% during mid-day trading on Tuesday . The stock traded as high as $1.45 and last traded at $1.45. Approximately 149,348 shares ...

TRINITY BIOTECH ($TRIB) is expected to release its quarterly earnings data on Thursday, May 22nd before market open, per Finnhub. Analysts are expecting revenue of ...

Oncolytics Biotech (NASDAQ:ONCY – Get Free Report)‘s stock had its “hold” rating reissued by research analysts at Jones Trading in a report released on Friday,Benzinga reports. Several other equities ...

Fortress Biotech amended a credit agreement to extend its maturity. The stock rose 4.8% to $4.40 in after-hours trading Monday. Par Technology was selected to be Papa John's International's new ...

09:35 EDT Zhengye Biotechnology (ZYBT) Holding Ltd trading halted, volatility trading pause Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor ...